Psychosocial barriers to successful insulin therapy in East Africa include lack of physician–patient interaction, understanding of diabetes and its treatments by both physicians and patients, and proper provision of testing and follow-up of patients [146]. This evidence concerns the gene INS and diabetes mellitus.